The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. (February 2020) - Campani, C.; Colagrande, S.; Calistri, L.; Dragoni, G.; Lorini, C.; Castellani, A.; Marra, F.